CAR T Cells Highly Successful in ALL – OncLive
OncLive |
CAR T Cells Highly Successful in ALL
OncLive Defined composition chimeric antigen receptor (CAR) T cells directed against CD19 have potent anti-tumor activity in B cell malignancies, including acute lymphocytic leukemia (ALL). The experience with CD19 CAR T cells in ALL was addressed by David … |
